Supplemental experimental protocols

In vivo I/R model
One hundred and five rats were randomly divided into four groups: sham control (SHAM) group, ischemia/reperfusion (I/R) group, SPC group and SEVO group.
Except the SHAM and SEVO groups, each rat was subjected to 30 min of LAD occlusion, followed by 2 h of reperfusion. In the SPC group, after 30 min of LAD occlusion, sevoflurane (H20130614, Maruishi Pharmaceutical Co, Chuoku, Osaka, Japan) was added to the inspired gas starting 1 min before reperfusion to achieve the concentration at 1.0 MAC. The rats inhaled 1.0 MAC sevoflurane for 15 min starting from the end of ischemia until 15 min after reperfusion, then reperfusion the hearts for 105 min. In the SEVO group, rats received 1.0 MAC sevoflurane for 15 min without occlusion. The experimental design is shown in Figure S1 .
Isolated I/R model
Sixty-three isolated perfused rat hearts were randomly divided into seven groups: SHAM group, I/R group, SPC group, DMSO group, BEZ group, BEZ + SPC group and SEVO group. Except the SHAM and SEVO groups, each rat was subjected to 30 min of global ischemia, followed by 2 h of reperfusion. In SPC and SEVO groups, the hearts were perfused with K-H solution saturated with 1.0 MAC sevoflurane for 15 min starting from the end of ischemia until 15 min after reperfusion, and then with plain K-H solution for 105 min. SPC was administrated as previously described 31 . In brief, sevoflurane was bubbled into the K-H solution by using an agent specific vaporizer (Vapor 2000; Dräger Medizintechnik GmbH, Lübeck, Germany) placed in the 95% O2-5% CO2 gas mixtures line at a concentration of (1.2±0.02) mmol/L (8%, v/v) measured in the liquid phase by a Datex infrared gas analyzer (Ohmeda, GE Healthcare), and ensure that the concentration of delivered sevoflurane in the K-H solution was maintained at 1.0 MAC. In BEZ and DMSO groups, the hearts were perfused with K-H solution saturated with the PI3K/mTOR dual inhibitor BEZ235 (20 umol/L, S1009, Selleck Chemicals, Boston, MA, USA) and 0.1% DMSO, respectively, for 15 min starting from the end of ischemia until 15 min after reperfusion, and then with plain K-H solution for 105 min. In BEZ + SPC group, BEZ235 was co-administered with sevoflurane for 15 min starting from the end of ischemia until 15 min after reperfusion. SEVO group received 1.0 MAC sevoflurane for 15 min without global cardiac I/R injury. The experimental design is shown in Figure S2 .
Histology
Following I/R, rat hearts were immediately removed, fixed in 10% formalin and then embedded in paraffin. The stainings of hematoxylin-eosin (H&E) were performed on paraffin-embedded myocardial sections (5 μm) and examined by light microscopy (n = 4 /group). 
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